ARJOHUNTLEIGH POLSKA Sp. z.o.o. vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for ARJOHUNTLEIGH POLSKA Sp. z.o.o..

ARJOHUNTLEIGH POLSKA Sp. z.o.o.: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Side by side

ARJOHUNTLEIGH POLSKA Sp. z.o.o. — Warning letters0

Philips North America — Warning letters0

ARJOHUNTLEIGH POLSKA Sp. z.o.o. — Recalls1

Philips North America — Recalls355

ARJOHUNTLEIGH POLSKA Sp. z.o.o. — Approval records0

Philips North America — Approval records0

ARJOHUNTLEIGH POLSKA Sp. z.o.o. — Form 483s0

Philips North America — Form 483s0

Timeline

ARJOHUNTLEIGH POLSKA Sp. z.o.o.

Most recent FDA action: April 22, 2026

Full history →

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"ARJOHUNTLEIGH POLSKA Sp. z.o.o. vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/arjohuntleigh-polska-sp-z-o-o-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗